# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-17-002461
Filing Date
2017-03-16
Accepted
2017-03-16 16:29:57
Documents
73
Period of Report
2016-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2016_actiniumpharma.htm | 10-K | 1455947
2 | FIFTH AMENDMENT TO THE 2013 AMENDED AND RESTATED STOCK PLAN | f10k2016ex10lix_actinium.htm | EX-10.59 | 9576
3 | AMENDMENT TO EMPLOYMENT AGREEMENT - DRAGAN CICIC | f10k2016ex10lx_actinium.htm | EX-10.60 | 10483
4 | AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA | f10k2016ex10lxi_actinium.htm | EX-10.61 | 5317
5 | AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA | f10k2016ex10lxii_actinium.htm | EX-10.62 | 5317
6 | WARRANT TO PURCHASE COMMON STOCK OF ACTINIUM PHARMACEUTICALS, INC., DATED MARCH | f10k2016ex10lxiii_actinium.htm | EX-10.63 | 107475
7 | OFFER LETTER - DR. MARK S. BERGER | f10k2016ex10lxiv_actinium.htm | EX-10.64 | 38092
8 | CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENT | f10k2016ex10lxv_actinium.htm | EX-10.65 | 53976
9 | INDEMNIFICATION AGREEMENT - MARK S. BERGER | f10k2016ex10lxvi_actinium.htm | EX-10.66 | 86814
10 | CONSENT OF GBH CPAS, PC | f10k2016ex23i_actinium.htm | EX-23.1 | 3177
11 | CERTIFICATION | f10k2016ex31i_actinium.htm | EX-31.1 | 10467
12 | CERTIFICATION | f10k2016ex31ii_actinium.htm | EX-31.2 | 10285
13 | CERTIFICATION | f10k2016ex32i_actinium.htm | EX-32.1 | 3198
14 | CERTIFICATION | f10k2016ex32ii_actinium.htm | EX-32.2 | 3262
21 | GRAPHIC | ex10lx_001.jpg | GRAPHIC | 12708
22 | GRAPHIC | ex10lxi_001.jpg | GRAPHIC | 12708
| Complete submission text file | 0001213900-17-002461.txt |  | 5574138

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
15 | XBRL INSTANCE FILE | atnm-20161231.xml | EX-101.INS | 800845
16 | XBRL SCHEMA FILE | atnm-20161231.xsd | EX-101.SCH | 52981
17 | XBRL CALCULATION FILE | atnm-20161231_cal.xml | EX-101.CAL | 30392
18 | XBRL DEFINITION FILE | atnm-20161231_def.xml | EX-101.DEF | 190236
19 | XBRL LABEL FILE | atnm-20161231_lab.xml | EX-101.LAB | 473507
20 | XBRL PRESENTATION FILE | atnm-20161231_pre.xml | EX-101.PRE | 310648

Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36374 | Film No.: 17694926
SIC: 2834 Pharmaceutical Preparations